Arjun Law

36PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersHaematologyRespiratory diseasesCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

|Apr 13, 2026
Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision-Making.

Arjun Datt Law, Jeffrey H Lipton

|Jan 28, 2026
The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes.

Ebaa Reda, Mohammed Kawari, Mariana Pinto Pereira

|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux

|Sep 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis.

Ruah Alyamany, Ahmed Alnughmush, Mats Remberger

|Sep 14, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.

Sergio Rodriguez-Rodriguez, Nihar Desai, Carol Chen

Pageof 6

Frequent Collaborators

20 joint publications

Rajat Kumar

18 joint publications

Dennis Kim

14 joint publications

Fotios V Michelis

13 joint publications

Ivan Pasic